Among the most popular fund investment industries, there are Pharmaceutical, Medical. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AM Pharma, Cellerix.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Biopartners Capital, startups are often financed by Ysios Capital, Ventech, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Ventech, Roche Venture Fund. In the next rounds fund is usually obtained by Ysios Capital, Idinvest Partners, Ventech.
This Biopartners Capital works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2011. The high activity for fund was in 2001.
Related Funds
| Fund Name | Location |
| Ahaka Capital | Canada, Montréal, Quebec |
| BigBasket | Bangalore, India, Karnataka |
| BlueSky Capital | Canada, Ontario, Toronto |
| Boardman Bay Capital Management | New York, New York, United States |
| CTI Life Sciences Fund | Canada, Montréal, Quebec |
| DB Investment Partners | New York, New York, United States |
| Dongzheng Rongtong Investment | Beijing, Beijing, China |
| Franchise Group | United States, Virginia, Virginia Beach |
| Inova Health System | Falls Church, United States, Virginia |
| Jianpu Technology | Beijing, Beijing, China |
| ORIX Group | Chiyoda, Japan |
| Plutus Wealth Management | England, London, United Kingdom |
| Polar Light Capital | Ansfelden, Austria, Oberosterreich |
| Praetura Ventures | England, Manchester, United Kingdom |
| Precedo Capital Group | Arizona, Paradise Valley, United States |
| Pulver's Micro Angel Fund | - |
| Sanmei Touzi | China, Guangdong, Guangzhou |
| The Abhoca Group | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellerix | $31M | 11 Nov 2009 | Community of Madrid | ||
AM Pharma | 26 Feb 2002 | Utrecht | |||
AM Pharma | $755K | 09 Aug 2001 | The Netherlands, Utrecht, Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellerix | $31M | 11 Nov 2009 | Community of Madrid | ||
AM Pharma | 26 Feb 2002 | Utrecht | |||
AM Pharma | $755K | 09 Aug 2001 | The Netherlands, Utrecht, Netherlands |
